Skip to main content

Care

By Mallory Hackett | 11:41 am | April 09, 2021
The digital therapeutic is designed to treat children ages 8 to 12 with ADHD, but the two studies announced this week will focus on an adult population.   
By Thiru Gunasegaran | 01:04 am | April 09, 2021
Using a phone’s camera and flash, the MFine Pulse detects light absorption in a user’s fingertip which is then processed via a proprietary algorithm to measure SpO2.
By Mallory Hackett | 03:52 pm | April 08, 2021
Starting this month, eligible Fitbit Sense users can participate in the study, which will look into how pulse arrival time can be used to measure blood pressure.   
By Tammy Lovell | 07:52 am | April 08, 2021
Funding will be used to gain in-human data for startup’s OxiFlow brain haemorrhage solution. 
By Mallory Hackett | 01:01 pm | April 07, 2021
The deal is expected to close this summer, subject to stockholder approval, and will raise $113 million for the combined company.   
By Sophie Porter | 12:38 pm | April 07, 2021
The technology release launches the delayed MedTech Funding Mandate that accelerates uptake of innovative treatments and therapies.
By Sara Mageit | 07:43 am | April 07, 2021
The company first collaborated with HSE on a pilot programme for psychological services in 2018.
By HIMSS TV | 06:02 pm | April 06, 2021
Empathetics founder and psychiatrist at Massachusetts General Hospital Dr. Helen Riess speaks with Frank Cutitta, who was hospitalized with COVID-19 for 100 days, about "institutionalized loneliness" and other emotional aftereffects of the pandemic.
By Mallory Hackett | 01:07 pm | April 06, 2021
Verizon introduces BlueJeans Telehealth platform for providers